Dermapharm Holding SE banner

Dermapharm Holding SE
DUS:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
DUS:DMP
Watchlist
Price: 37.45 EUR -1.45%
Market Cap: €4B

Wall St Price Targets

DMP Price Targets Summary
Dermapharm Holding SE

Wall Street analysts forecast DMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMP is 51.83 EUR with a low forecast of 45.16 EUR and a high forecast of 64.02 EUR.

Lowest Forecast
Price Target
45.16 EUR
21% Upside
Average Forecast
Price Target
51.83 EUR
38% Upside
Highest Forecast
Price Target
64.02 EUR
71% Upside
Dermapharm Holding SE Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.

Gross Profit
Forecast

16% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
16% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.

Operating Income
Forecast

13% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
13% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
13% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 10%.

Net Income
Forecast

26% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
26% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DMP's stock price target?
Price Target
51.83 EUR

According to Wall Street analysts, the average 1-year price target for DMP is 51.83 EUR with a low forecast of 45.16 EUR and a high forecast of 64.02 EUR.

What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%

Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.

What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.

What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%

Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.

What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
10%

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 10%.

What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
9%

Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 9%.

Back to Top